Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefe T Chan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The EMBO Journal|September 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesisEric P Kusnadi, Anna S Trigos, Carleen Cullinane, et al.
Oncotarget|July 9, 2016
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signalingJaclyn Quin, Keefe T Chan, Jennifer R Devlin, et al.
Nature Communications|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancerElaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaCraig C Carson, Stergios J Moschos, Sharon N Edmiston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The EMBO Journal|September 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesisEric P Kusnadi, Anna S Trigos, Carleen Cullinane, et al.
Oncotarget|July 9, 2016
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signalingJaclyn Quin, Keefe T Chan, Jennifer R Devlin, et al.
Nature Communications|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancerElaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaCraig C Carson, Stergios J Moschos, Sharon N Edmiston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Pageof 3